ATE480771T1 - Ionenkanal-assayverfahren - Google Patents

Ionenkanal-assayverfahren

Info

Publication number
ATE480771T1
ATE480771T1 AT06019986T AT06019986T ATE480771T1 AT E480771 T1 ATE480771 T1 AT E480771T1 AT 06019986 T AT06019986 T AT 06019986T AT 06019986 T AT06019986 T AT 06019986T AT E480771 T1 ATE480771 T1 AT E480771T1
Authority
AT
Austria
Prior art keywords
ion channel
assay method
channel assay
candidate compound
cells
Prior art date
Application number
AT06019986T
Other languages
English (en)
Inventor
Michael P Maher
Jesus E Gonzales Iii
Original Assignee
Vertex Pharma San Diego Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/804,457 external-priority patent/US7399599B2/en
Application filed by Vertex Pharma San Diego Llc filed Critical Vertex Pharma San Diego Llc
Application granted granted Critical
Publication of ATE480771T1 publication Critical patent/ATE480771T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
AT06019986T 2000-07-10 2001-07-09 Ionenkanal-assayverfahren ATE480771T1 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US21766600P 2000-07-10 2000-07-10
US21721900P 2000-07-10 2000-07-10
US21722100P 2000-07-10 2000-07-10
US21767100P 2000-07-10 2000-07-10
US09/804,457 US7399599B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods
US09/804,458 US6969449B2 (en) 2000-07-10 2001-03-12 Multi-well plate and electrode assemblies for ion channel assays
US09/804,580 US6686193B2 (en) 2000-07-10 2001-03-12 High throughput method and system for screening candidate compounds for activity against target ion channels
US09/804,480 US7312043B2 (en) 2000-07-10 2001-03-12 Ion channel assay methods

Publications (1)

Publication Number Publication Date
ATE480771T1 true ATE480771T1 (de) 2010-09-15

Family

ID=27575195

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01953433T ATE342504T1 (de) 2000-07-10 2001-07-09 Ionenkanal-testverfahren
AT06019986T ATE480771T1 (de) 2000-07-10 2001-07-09 Ionenkanal-assayverfahren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01953433T ATE342504T1 (de) 2000-07-10 2001-07-09 Ionenkanal-testverfahren

Country Status (10)

Country Link
EP (2) EP1303757B1 (de)
JP (1) JP5209835B2 (de)
AT (2) ATE342504T1 (de)
AU (4) AU2001275881B2 (de)
CA (1) CA2413711C (de)
DE (2) DE60123797T2 (de)
DK (1) DK1303757T3 (de)
ES (1) ES2273868T3 (de)
MX (1) MXJL03000001A (de)
WO (1) WO2002008748A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144905A1 (en) 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US7244349B2 (en) 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US7615356B2 (en) * 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
EP1303757B1 (de) * 2000-07-10 2006-10-11 Vertex Pharmaceuticals (San Diego) LLC Ionenkanal-testverfahren
US7067046B2 (en) 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
WO2003006103A2 (en) * 2001-07-12 2003-01-23 Merck & Co., Inc. Electrical field stimulation of eukaryotic cells
WO2003035824A1 (en) * 2001-10-25 2003-05-01 Bar-Ilan University Interactive transparent individual cells biochip processor
US8003372B2 (en) 2002-02-05 2011-08-23 The University Court Of The University Of Glasgow Device for performing cell assays
AU2003283663A1 (en) * 2002-11-01 2004-05-25 Cellectricon Ab Computer programs,workstations, systems and methods for microfluidic substrates in cell
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
ES2294757T3 (es) * 2004-03-15 2008-04-01 Amaxa Ag Recipiente y dispositivo para generar campos electricos en espacios de reaccion individuales.
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
US9975118B2 (en) 2007-11-15 2018-05-22 Seng Enterprises Ltd. Device for the study of living cells
GB0723725D0 (en) * 2007-12-05 2008-01-16 Ge Healthcare Uk Ltd Apparatus and method for detecting dna damage
CA2727818A1 (en) * 2008-06-13 2009-12-13 Scott And White Healthcare Characterization of biological samples
US8221411B2 (en) * 2008-07-28 2012-07-17 Medtronic, Inc. Systems and methods for cardiac tissue electroporation ablation
EP2278332A1 (de) 2009-07-20 2011-01-26 Fondazione Centro San Raffaele del Monte Tabor Verfahren zur optischen Messung von Abweichungen der Zellmembranleitfähigkeit
JP5411096B2 (ja) * 2010-08-31 2014-02-12 株式会社堀場製作所 粒子物性測定セル及び粒子物性測定装置
WO2014065330A1 (ja) * 2012-10-25 2014-05-01 浜松ホトニクス株式会社 細胞観察装置、電気刺激装置、及び細胞観察方法
EP2913391B1 (de) * 2012-10-25 2020-07-01 Hamamatsu Photonics K.K. Zellbeobachtungsvorrichtung und zellbeobachtungsverfahren
JP6337109B2 (ja) 2013-07-19 2018-06-06 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated ナトリウムチャネルの調節剤としてのスルホンアミド
JP6463580B2 (ja) 2013-12-13 2019-02-06 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated ナトリウムチャネルの調節剤として有用なピリドンアミドのプロドラッグ
JP6822960B2 (ja) 2014-12-19 2021-01-27 ジ ユニバーシティ オブ オタワ 制御破壊を用いた複数のマイクロ流体チャネルアレイにおけるナノポアセンサの一体化
BR112019024016A2 (pt) 2017-05-16 2020-06-09 Vertex Pharma amidas de piridona deuteradas e profármacos das mesmas como moduladores de canais de sódio
CN116987589A (zh) * 2017-10-19 2023-11-03 苏州壹达生物科技有限公司 一种流式电穿孔装置
EP3752152A1 (de) 2018-02-12 2020-12-23 Vertex Pharmaceuticals Incorporated Verfahren zur behandlung von schmerz
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
DK4069691T3 (da) 2019-12-06 2024-10-28 Vertex Pharma Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
EP4347033A1 (de) 2021-06-04 2024-04-10 Vertex Pharmaceuticals Incorporated Hydroxy- und (halo)alkoxy-substituierte tetrahydrofurane als modulatoren von natriumkanälen
MA64853B1 (fr) 2021-06-04 2025-11-28 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hétéro)aryl) tétrahydrofuran carboxamides utilisés en tant que modulateurs de canaux sodiques
CA3221939A1 (en) 2021-06-04 2022-12-08 Vertex Pharmaceuticals Incorporated N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels
JP2024520649A (ja) 2021-06-04 2024-05-24 バーテックス ファーマシューティカルズ インコーポレイテッド (2r,3s,4s,5r)-4-[[3-(3,4-ジフルオロ-2-メトキシ-フェニル)-4,5-ジメチル-5-(トリフルオロメチル)テトラヒドロフラン-2-カルボニル]アミノ]ピリジン-2-カルボキサミドを含む固体剤形及び投与レジメン
DE102021210044A1 (de) 2021-09-10 2023-03-16 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein Messsystem, Probenkörper, Elektrodenvorrichtung und Verfahren zum Messen einer Vielzahl von Analyten
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
WO2025090465A1 (en) 2023-10-23 2025-05-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
WO2025090436A1 (en) * 2023-10-25 2025-05-01 St. Jude Medical, Cardiology Division, Inc. Systems and methods for reducing microbubbles in electroporation applications
US20260001877A1 (en) 2024-06-28 2026-01-01 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067951A (en) * 1975-11-19 1978-01-10 Bactomatic Inc. Process for making impedance measuring module
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US5187096A (en) * 1991-08-08 1993-02-16 Rensselaer Polytechnic Institute Cell substrate electrical impedance sensor with multiple electrode array
JP3099049B2 (ja) * 1992-07-29 2000-10-16 農林水産省果樹試験場長 電気的細胞融合及び電気的核酸導入のための大量処理用電極
US5661035A (en) * 1995-06-07 1997-08-26 The Regents Of The University Of California Voltage sensing by fluorescence resonance energy transfer
DE19529371C3 (de) * 1995-08-10 2003-05-28 Nmi Univ Tuebingen Mikroelektroden-Anordnung
US6099960A (en) * 1996-05-15 2000-08-08 Hyperion Catalysis International High surface area nanofibers, methods of making, methods of using and products containing same
US5972694A (en) * 1997-02-11 1999-10-26 Mathus; Gregory Multi-well plate
US5981268A (en) * 1997-05-30 1999-11-09 Board Of Trustees, Leland Stanford, Jr. University Hybrid biosensors
AU2150300A (en) * 1998-12-07 2000-06-26 Acacia Biosciences Inc. Multi-channel electrode arrays
US7312043B2 (en) * 2000-07-10 2007-12-25 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
EP1303757B1 (de) * 2000-07-10 2006-10-11 Vertex Pharmaceuticals (San Diego) LLC Ionenkanal-testverfahren

Also Published As

Publication number Publication date
EP1757932A2 (de) 2007-02-28
EP1757932B1 (de) 2010-09-08
ES2273868T3 (es) 2007-05-16
AU2009212941B2 (en) 2012-06-28
DE60143064D1 (de) 2010-10-21
AU2009212941A1 (en) 2009-10-01
EP1303757B1 (de) 2006-10-11
AU7588101A (en) 2002-02-05
WO2002008748A9 (en) 2003-06-12
AU2006202851B2 (en) 2009-06-04
WO2002008748A3 (en) 2002-05-02
JP5209835B2 (ja) 2013-06-12
EP1303757A2 (de) 2003-04-23
AU2001275881B2 (en) 2006-04-06
DK1303757T3 (da) 2007-02-05
MXJL03000001A (es) 2004-02-09
DE60123797T2 (de) 2007-10-18
CA2413711C (en) 2012-03-13
CA2413711A1 (en) 2002-01-31
WO2002008748A2 (en) 2002-01-31
DE60123797D1 (de) 2006-11-23
EP1757932A3 (de) 2007-07-18
ATE342504T1 (de) 2006-11-15
AU2006202851A1 (en) 2006-07-27
JP2004514115A (ja) 2004-05-13

Similar Documents

Publication Publication Date Title
ATE480771T1 (de) Ionenkanal-assayverfahren
WO2005022113A3 (en) Ion channel assay methods
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DE60124301D1 (de) Dünnschichtelektroden zum feststellen von herzdepolarisationsignalen
ID24376A (id) Turunan-turunan asam amidokarboksilat
ATE383331T1 (de) Transportreagentien
ATE212661T1 (de) Durch enzymkatalyse erhaltene therapeutische substanzen.
DK1114482T3 (da) Bipolær elektrode for elektrokemiske redoxreaktioner
DE69836490D1 (de) Verbesserte elektrochemische zelle
DE69426956D1 (de) Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
ATE502116T1 (de) Fluoreszierende proteine aus nicht- biolumineszenten arten der klasse anthozoa, gene die diese proteine kodieren und deren verwendungen
DE60318642D1 (de) Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen
ATE408005T1 (de) Makroeingekapselte sekretorische zellen
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
DK0981520T3 (da) Effektiv enantioselektiv tilsætningsreaktion under anvendelse af et organozinkreagens
ATE267396T1 (de) Identifizierung von zellen während kinetischer versuchsreihen
DE60108504D1 (de) Kathodenanordnung für eine indirekt geheizte kathode einer ionenquelle
DE69907182D1 (de) Elektrochemische zelle
WO2003098661A3 (en) Chemical and biological hazard sensor system and methods thereof
AU1810101A (en) Capillary electrophoresis probes and method
DE60024451D1 (de) Bindung mehrerer zinkfinger transkriptionsfaktoren an nukleinsäuren
ATE322898T1 (de) Inhibitoren von mycobakterien
ID23462A (id) Proses untuk pirolidinil senyawa-senyawa asam hidroksamat
EP1312915A4 (de) Elektrophorese-analyseverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties